Slocum, Gordon & Co LLP
•CIK: 1993325•Filing: Q4 2025
**Slocum, Gordon & Co LLP** manages $138M across a diversified portfolio of 60 positions. The fund exhibits a significant allocation to established healthcare and energy names, notably holding $10.1M in Merck (MRK) and $9.0M in Johnson & Johnson (JNJ). Further concentration is evident in utilities and energy, with combined top holdings in NEE, XOM, and AEP exceeding $24M. This structure suggests a value-oriented approach targeting defensive growth within large-cap sectors.
Total AUM
$138.1M
QoQ Performance
+10.1%
Positions
57
Top 10 Concentration
51.6%
Latest Filing
Q4 2025
Top Holdings Allocation
MRK
JNJ
NEE
XOM
AEP
PG
MRK7.3%
JNJ6.5%
NEE6.2%
XOM6.2%
AEP5.6%
PG5.2%
PPL4.0%
BAC3.6%
📈 Biggest Buys
📉 Biggest Sells
Sector Breakdown
Other37.8%
Healthcare19.5%
Utilities9.3%
Energy9.0%
Financial6.9%
Industrial5.6%
Consumer5.6%
Technology4.2%
Changes from Q3 2025
NEW6 new positions
↑13 increased
↓25 decreased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023